Suppr超能文献

围绝经期和绝经后早期女性自我报告的口服避孕药使用情况与自动药房数据的比较。

A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women.

作者信息

Spangler Leslie, Ichikawa Laura E, Hubbard Rebecca A, Operskalski Belinda, LaCroix Andrea Z, Ott Susan M, Scholes Delia

机构信息

Center for Observational Research, Amgen Inc., Thousand Oaks, CA.

Group Health Research Institute, Group Health Cooperative, Seattle, WA.

出版信息

Ann Epidemiol. 2015 Jan;25(1):55-9. doi: 10.1016/j.annepidem.2014.10.009. Epub 2014 Oct 16.

Abstract

PURPOSE

Oral contraceptive (OC) use can occur throughout a woman's reproductive life span with the potential for long-term impacts on health. To assess potential measurement error in prior OC use, this study compared level of agreement between self-reported prior OC use and pharmacy dispensing data in perimenopausal and/or early postmenopausal women.

METHODS

The study's 1399 women (ages, 45-59 years) were participants in a population-based case-control study of the association between OC use and fracture risk. Episodes of lifetime self-reported OC use (in months) were collected, by telephone interview, for January 1, 2008 through November 25, 2012. Pharmacy fills, back to 1980, were collected from automated data. Agreement was measured using the prevalence-adjusted and bias-adjusted kappa index.

RESULTS

The number of women with OC pharmacy fills was 11% to 45% higher than those who reported OC use during each time period. Between-measures agreement was better for more recent use. Prevalence-adjusted and bias-adjusted kappa index values ranged from 0.88 (95% confidence interval, 0.85-0.90) within 5 years from the reference date to 0.65 (95% confidence interval, 0.59-0.71) within 15 to 20 years.

CONCLUSIONS

For studies designed to assess the long-term effects of OC use, the current results are reassuring in noting moderate agreement between self-reported OC use and pharmacy data for up to 15 to 20 years before the interview.

摘要

目的

口服避孕药(OC)的使用贯穿女性的整个生殖寿命期,可能对健康产生长期影响。为评估既往OC使用情况潜在的测量误差,本研究比较了围绝经期和/或绝经后早期女性自我报告的既往OC使用情况与药房配药数据之间的一致性水平。

方法

该研究中的1399名女性(年龄45 - 59岁)参与了一项基于人群的病例对照研究,该研究旨在探讨OC使用与骨折风险之间的关联。通过电话访谈收集了2008年1月1日至2012年11月25日期间自我报告的终身OC使用时长(以月为单位)。从自动化数据中收集了可追溯至1980年的药房配药记录。使用患病率调整和偏差调整的kappa指数来衡量一致性。

结果

在每个时间段内,有OC药房配药记录的女性人数比报告使用OC的女性人数高11%至45%。对于更近时期的使用,不同测量方法之间的一致性更好。患病率调整和偏差调整的kappa指数值范围从参考日期起5年内的0.88(95%置信区间,0.85 - 0.90)到15至20年内的0.65(95%置信区间,0.59 - 0.71)。

结论

对于旨在评估OC使用长期影响的研究,当前结果令人安心,因为在访谈前长达15至20年的时间里,自我报告的OC使用情况与药房数据之间存在适度的一致性。

相似文献

1
A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women.
Ann Epidemiol. 2015 Jan;25(1):55-9. doi: 10.1016/j.annepidem.2014.10.009. Epub 2014 Oct 16.
2
Oral contraceptive use: interview data versus pharmacy records.
Int J Epidemiol. 1998 Dec;27(6):1033-7. doi: 10.1093/ije/27.6.1033.
4
Pharmacy claims data versus patient self-report to measure contraceptive method continuation.
Contraception. 2015 Jul;92(1):26-30. doi: 10.1016/j.contraception.2015.03.016. Epub 2015 Apr 7.
5
Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study.
Fertil Steril. 2005 Aug;84(2):374-83. doi: 10.1016/j.fertnstert.2005.01.132.
6
Agreement between women's histories of oral contraceptive use and physician records.
Int J Epidemiol. 1983 Mar;12(1):84-7. doi: 10.1093/ije/12.1.84.

引用本文的文献

1
Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women.
PLoS One. 2024 May 23;19(5):e0303823. doi: 10.1371/journal.pone.0303823. eCollection 2024.
2
Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels.
Fertil Steril. 2021 Jul;116(1):208-217. doi: 10.1016/j.fertnstert.2021.02.007. Epub 2021 Mar 19.
3
Misreporting of contraceptive hormone use in clinical research participants.
Contraception. 2018 Apr;97(4):346-353. doi: 10.1016/j.contraception.2017.09.013. Epub 2017 Sep 28.
4
Oral contraceptive use and fracture risk around the menopausal transition.
Menopause. 2016 Feb;23(2):166-74. doi: 10.1097/GME.0000000000000595.

本文引用的文献

1
Types of combined oral contraceptives used by US women.
Contraception. 2012 Dec;86(6):659-65. doi: 10.1016/j.contraception.2012.05.017. Epub 2012 Jul 6.
2
Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data.
J Clin Epidemiol. 2011 Aug;64(8):821-9. doi: 10.1016/j.jclinepi.2010.10.006. Epub 2010 Dec 30.
3
Statin use and breast cancer risk in a large population-based setting.
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):416-21. doi: 10.1158/1055-9965.EPI-06-0737.
4
Reliability of Group Health Cooperative automated pharmacy data by drug benefit status.
Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):877-84. doi: 10.1002/pds.1119.
6
Pharmacy data in epidemiological studies: an easy to obtain and reliable tool.
Pharmacoepidemiol Drug Saf. 2002 Jul-Aug;11(5):379-84. doi: 10.1002/pds.722.
7
Oral contraceptive use: interview data versus pharmacy records.
Int J Epidemiol. 1998 Dec;27(6):1033-7. doi: 10.1093/ije/27.6.1033.
9
Bias, prevalence and kappa.
J Clin Epidemiol. 1993 May;46(5):423-9. doi: 10.1016/0895-4356(93)90018-v.
10
Comparison of recalled and validated oral contraceptive histories.
Am J Epidemiol. 1993 Nov 1;138(9):697-703. doi: 10.1093/oxfordjournals.aje.a116907.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验